Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Louis J. Vollmer Named Iroko’s CEO

Executive Summary

Iroko Pharmaceuticals LLC. has appointed Louis J. Vollmer president and CEO. Vollmer has been president of Iroko since March 2015 and continues as a member of the company’s board of directors. He succeeds as CEO Osagie Imasogie, Iroko’s founder, who will continue as the company’s chair. Vollmer started his career at DuPont Merck where he ultimately served as vice president of sales and marketing for DuPont Multi Source Products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC096907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel